SOURCE: Antisoma plc

June 15, 2009 07:14 ET

Antisoma to present at 3rd Annual Jefferies Healthcare Conference in New York

LONDON, UK--(Marketwire - June 15, 2009) -

15 June 2009, London, UK, and Cambridge, MA: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that Dr Michael Boss (General Manager, Autoimmune) will present an overview of the Company's strategy, programmes and prospects at the 3rd Annual Jefferies Healthcare Conference in New York on Thursday Jun 18th at 14:00 EDT/19:00 BST.

A webcast of the presentation will be available on Antisoma's website at

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

Alison Saville
Communications Executive
Antisoma plc
+44 (0)20 3249 2100

Background on Antisoma

Antisoma is a London Stock Exchange-listed biopharmaceutical company that develops novel products for the treatment of cancer. The Company has operations in the UK and the US. Please visit for further information about Antisoma.


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Contact Information